Trinity Biotech reported $1.21M in Ordinary Share Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Bayer BAYN:GR € 2515M 0M
Cytori Therapeutics CYTX:US $ 0.02M 0M
Mesa Laboratories MLAB:US $ 302.23M 4.03M
Oxford Immunotec Global OXFD:US $ 0.27M 0M
Siemens SIE:GR € 2550M 0M
Tosoh 4042:JP Y 55173M 0M
Trinity Biotech TRIB:US $ 1.21M 0M
Veracyte VCYT:US $ 0.07M 0M